全文获取类型
收费全文 | 1736篇 |
免费 | 83篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 33篇 |
妇产科学 | 6篇 |
基础医学 | 249篇 |
口腔科学 | 48篇 |
临床医学 | 92篇 |
内科学 | 441篇 |
皮肤病学 | 14篇 |
神经病学 | 100篇 |
特种医学 | 47篇 |
外科学 | 392篇 |
综合类 | 19篇 |
预防医学 | 19篇 |
眼科学 | 131篇 |
药学 | 53篇 |
中国医学 | 1篇 |
肿瘤学 | 181篇 |
出版年
2023年 | 7篇 |
2022年 | 13篇 |
2021年 | 16篇 |
2020年 | 11篇 |
2019年 | 11篇 |
2018年 | 20篇 |
2017年 | 18篇 |
2016年 | 23篇 |
2015年 | 28篇 |
2014年 | 36篇 |
2013年 | 48篇 |
2012年 | 77篇 |
2011年 | 100篇 |
2010年 | 47篇 |
2009年 | 54篇 |
2008年 | 106篇 |
2007年 | 137篇 |
2006年 | 119篇 |
2005年 | 119篇 |
2004年 | 112篇 |
2003年 | 115篇 |
2002年 | 127篇 |
2001年 | 39篇 |
2000年 | 39篇 |
1999年 | 47篇 |
1998年 | 33篇 |
1997年 | 15篇 |
1996年 | 20篇 |
1995年 | 23篇 |
1994年 | 27篇 |
1993年 | 16篇 |
1992年 | 11篇 |
1991年 | 16篇 |
1990年 | 16篇 |
1989年 | 18篇 |
1988年 | 19篇 |
1987年 | 20篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1984年 | 9篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1979年 | 9篇 |
1978年 | 12篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1974年 | 11篇 |
1971年 | 5篇 |
排序方式: 共有1838条查询结果,搜索用时 15 毫秒
81.
The current state of neurosurgery in Japan 总被引:1,自引:0,他引:1
JAPAN HAS TWO large neurosurgical societies, the Japan Neurosurgical Society (JNS) and the Japanese Congress of Neurological Surgeons (Japanese CNS). The JNS was founded in 1948, and the Japanese CNS in 1981. The total number of neurosurgeons in Japan exceeds 7500, with 5432 board certified. There are 1340 training centers for neurosurgery in Japan; they are classified into two categories: Category A centers and Category C centers (training subcenters). For a neurosurgeon to be eligible to take the specialty board examination, he or she is required to have finished at least 6 years of training at a designated training center. A characteristic of Japanese neurosurgery is that neurosurgeons are engaged not only in surgical operations but also in various related activities, including performing radiological diagnostic procedures, such as angiography and endovascular surgery; working in the emergency room; and sometimes participating in neurorehabilitation and gamma knife treatment. In addition, a large number of neurosurgeons are engaged in research in various related fields. The JNS began to publish its official journal in 1948, initially in the Japanese language. Since 1990, the journal has been published exclusively in English (Neurologia Medico-chirurgica), whereas the official journal of the Japanese CNS is published in Japanese (Japanese Journal of Neurosurgery). Japan is blessed with advanced diagnostic and surgical technologies and instruments. They are available as needed throughout the country. Medical insurance is fully covered by the government or public insurance system; there is basically no private insurance in Japan. This article mentions socioeconomic problems relating to neurosurgical practice. 相似文献
82.
Teshima H Hayashida N Nishimi M Tayama E Fukunaga S Tomoeda H Chihara S Enomoto N Kawara T Aoyagi S 《Artificial organs》2002,26(5):460-466
This study was conducted to determine the effect of thrombolytic therapy with tissue plasminogen activator (t-PA) for nonstructural malfunction of bileaflet cardiac valve prostheses. Twenty-seven patients with bileaflet prosthetic valve malfunction diagnosed by a combination of cineradiography and transthoracic echocardiography were treated with the administration of intravenous t-PA. The treatment resulted in complete success in 55.6% (15 of 27), partial success in 22.2% (6 of 27), and no change in 22.2% (6 of 27). In the complete success and partial success groups, the condition of the patients in 85.7% (18 of 21) of the cases improved within 24 h after the administration of t-PA. Six cases in whom thrombolytic therapy was instituted more than 1 month (ranged from 1 to 38 months, mean 14.7 months) after the diagnosis of prosthetic valve malfunction showed significantly less effectiveness of thrombolytic therapy with t-PA. Only one patient (3.7%) had a major complication (thromboembolism) after t-PA treatment. The results suggest that thrombolytic therapy with t-PA in patients with nonstructural malfunction of bileaflet cardiac valve prostheses is effective with low incidence of complication when the treatment is instituted early after the diagnosis. 相似文献
83.
84.
Sunakawa K Nonoyama M Fujii R Iwai N Sakata H Shirai M Sato T Kajino M Toyonaga Y Sano T Naito A Minagawa K Niida Y Oda T Yokozawa M Asanuma H Shimura K Fujimura M Kitajima H Fujinami K Numazaki K Fujikawa T Kobayashi Y Sato Y Nishimura T Iwata S Tsuchihashi N Oishi T Matsumoto S Motohiro T Osawa M Sunahara M Shirakawa S Nishida H Takahashi N Nakano R Sai N Iyoda K Yoshimitsu K Ogawa K Okazaki T Tsukimoto I Motoyama O Takada Y Kawasaki M Sunaoshi W Nakamura S Ueda Y Kamata M Kato T Chiba M 《The Japanese journal of antibiotics》2002,55(5):656-677
Pharmacokinetics, clinical efficacy and safety of teicoplanin (TEIC) were evaluated in pediatric and neonate patients with MRSA sepsis in the dosages approved in overseas. The administrated dose for pediatrics patients was 10 mg/kg once at hour 0, 12 and 24, followed by every 24 hours intervals. In neonates patients, first dose was 16 mg/kg, then 8 mg/kg every 24 hours intervals. 1. Pharmacokinetic results. All 17 patients (9 neonates and 8 pediatrics) who received TEIC were evaluated for pharmacokinetics. Trough concentrations were analyzed in 16 patients (9 neonates and 7 pediatrics) excluding one patient for lack of measurement of drug concentration at day 7. No patient with a concentration exceeding 60 micrograms/mL in peak or trough concentrations were reported. Mean concentrations in trough at day 3, 4 and 7 in neonates were 15.2, 14.7 and 17.8 micrograms/mL, and in pediatrics were 12.5, 12.2 and 13.1 micrograms/mL, respectively. These results were similar to those reported in foreign pediatrics and neonates patients. 2. Efficacy and safety results. Since no patient was excluded, all patients were evaluated for efficacy and safety. Microbiological efficacy as well as clinical cure were secondarily evaluated in 2 patients for whom MRSA was isolated from blood. Clinical efficacy rate was 76.5% (13/17) and number of cases in judgments of excellent, good, fairly improved and no change were 12, 1, 3 and 1 cases respectively. The patients for whom MRSA was isolated from blood were judged as MRSA eradicated case and cured without any additional anti-MRSA drugs. Adverse events were reported in 2 neonates and 3 pediatric patients. Possibly related adverse events to study drug (adverse drug reactions) were: 1 case of respiratory disorder, thrombocythemia, gamma-GTP increased, GOT increased and GPT increased in 3 pediatrics. These results suggest that an application of overseas dose regimen of TEIC for neonate and pediatrics is appropriate in Japan. 相似文献
85.
Nishimura M Ohtake S Sawa Y Takahashi T Matsumiya G Kagisaki K Miyamoto Y Matsuda H 《The Annals of thoracic surgery》2002,74(4):1264-1266
We describe a modified arch-first technique for total arch replacement through median sternotomy. This technique involves a short period of circulatory arrest (less than 30 minutes) and subsequent anterior cerebral perfusion. It does not require cannulation of the carotid vessels, which can cause cerebral thromboembolism, and it enables anterior cerebral perfusion to be resumed after a relatively short period of circulatory arrest. This appears to be a useful technique to reduce cerebral complications in complicated arch reconstruction operation for patients with severely atherosclerotic carotid vessels. 相似文献
86.
Yamada T Ishida K Yokoi S Nakano M Ehara H Takahashi Y Ishihara S Deguchi T 《Hinyokika kiyo. Acta urologica Japonica》2002,48(7):431-434
We report a case of ACTH-independent macronodular adrenal hyperplasia (AIMAH). A 62-year-old man was admitted to our hospital for further examination of obesity and diabetes mellitus. He was diagnosed with Cushing's syndrome by endocrinological examinations, and computed tomography and magnetic resonance imaging findings revealed nodular hyperplasia in bilateral adrenal glands, suggesting its etiology to be AIMAH. We underwent simultaneous bilateral laparoscopic adrenalectomy. A preoperative diagnosis of AIMAH was confirmed by histological examination of both adrenal glands, weighing 21 g (right) and 16 g (left). The postoperative course was uneventful. We believe that simultaneous bilateral laparoscopic adrenalectomy is feasible, safe, and results in minimal postoperative morbidity for the treatment of AIMAH. 相似文献
87.
Fukumoto S Shirato H Shimzu S Ogura S Onimaru R Kitamura K Yamazaki K Miyasaka K Nishimura M Dosaka-Akita H 《Cancer》2002,95(7):1546-1553
BACKGROUND: Occasionally, medically compromised and/or elderly patients with nonsmall cell lung carcinomas (NSCLCs) cannot be treated surgically. We investigated small-volume hypofractionated image-guided radiotherapy (IGRT) without the need for breath control in patients with inoperable Stage I NSCLCs. METHODS: Between September 1996 and September 1999, 22 patients with Stage I NSCLCs, including 19 males and 3 females, were treated with IGRT. Among these patients, there were 13 Stage IA and 9 Stage IB tumors. The tumors ranged in size from 14.2 to 58.5 mm, with a median size of 26.7 mm. Of the 22 patients, 19 were unfit for surgical treatment due to poor pulmonary function, complications, and/or advanced age and 3 refused surgery. Computed tomographic scans (CT) of the primary tumor were taken during three respiratory phases and they were analyzed to determine the planning target volume, which included only the primary tumor with allowances for respiratory movement. The radiation doses administered at the edge of the moving tumor during normal breathing were 80% of the prescribed dose, either 48 or 60 Gy given in eight fractions over 2 weeks. Clinical evaluation, chest CT scan, and pulmonary function tests were performed before irradiation and at regular intervals for the post-IGRT follow-up. The median follow-up period was 24 months (range, 2-44 months; mean, 21.8 months) (at least 24 months for survivors). RESULTS: Of 17 tumors assessed at the initial follow-up 2-6 months after treatment (5 complete responses, 11 partial responses, and 1 progressive disease), 16 (94%) were controlled locally. One local recurrence was observed during the follow-up. The lung carcinoma-specific survival rate at 1 year was 94% and the 1-year actuarial recurrence-free survival rate was 71%. The lung carcinoma-specific survival rate at 2 years was 73% and the 2-year actuarial recurrence-free survival rate was 67%. The treatment was well tolerated and no major side effects were observed. Localized radiation pneumonitis was observed in all patients who were examined by CT scan, but the patients were asymptomatic. Parameters of pulmonary function, including vital capacity, total lung capacity, and diffusion capacity for carbon monoxide, decreased very little or not at all, indicating that IGRT rarely deteriorated pulmonary functions. CONCLUSIONS: Small-volume hypofractionated IGRT without breath control is a feasible and beneficial method for the curative treatment of patients with Stage I NSCLCs. It has the potential of a high local tumor control rate and low morbidity. 相似文献
88.
Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas 总被引:2,自引:0,他引:2
Hommura F Furuuchi K Yamazaki K Ogura S Kinoshita I Shimizu M Moriuchi T Katoh H Nishimura M Dosaka-Akita H 《Cancer》2002,94(3):752-758
BACKGROUND: beta-Catenin has been shown to function as a Wnt signaling molecule to stimulate cyclin D1 expression and cell growth in several kinds of tumors. METHODS: The authors immunohistochemically examined specimens of 217 surgically resected primary nonsmall cell lung carcinomas (NSCLCs) for beta-catenin expression and classified them semiquantitatively into three categories, including those with high, moderate, and low scores of expression. RESULTS: High, moderate, and low scores of expression were found in 37 (17.1%), 145 (66.8%), and 35 (16.1%) tumors, respectively. beta-Catenin expression was not correlated with cyclin D1 expression, but was positively correlated with the Ki-67 cell growth fraction (P = 0.04). The direct sequencing analysis for the beta-catenin gene mutation of 13 specimens of 217 tumors for the current study revealed no mutations. The relation between survival and beta-catenin expression was evaluated in 148 potentially curatively resected tumors with pathologic Stages I-IIIA. A trend toward better survival was found in patients with tumors having higher scores. In multivariate analysis, high beta-catenin expression was a significant and independent favorable prognostic factor (hazards ratio, 0.31; P = 0.007) as was pathologic stage. Analyzed by cell type, in nonsquamous cell carcinomas, patients with tumors having high scores survived a significantly longer time than those with tumors having moderate or low scores (5-year survival rates, 84%, 55%, and 32%, respectively; P = 0.02), and high beta-catenin expression tended to be a favorable prognostic factor (hazards ratio, 0.32; P = 0.052). CONCLUSIONS: These results indicate that, in NSCLCs, increased expression of beta-catenin can predict favorable prognosis of patients with resected tumors, suggesting that accumulation of beta-catenin has no or little oncogenic effect via activation of the Wnt pathway, unlike in colon carcinomas or hepatomas. 相似文献
89.
Hotokezaka M Ishimitsu T Matsumoto S Nakamura K Takeda S 《Gan to kagaku ryoho. Cancer & chemotherapy》2002,29(6):955-958
In a 79-year-old man with ascending colon cancer, multiple liver metastases were detected by computer tomography. The patient underwent right hemicolectomy. Paraaortic lymph nodes metastases were found intraoperatively. After surgery, 5'-deoxy-5-fluorouridine (5'-DFUR) was administered orally at 600 mg daily. Abdominal CT showed disappearance of the liver metastases 6 months after operation. At a follow-up exam 24 months after the beginning of the chemotherapy, the patient remained in remission and reported no side effects. We consider oral administration of 5'-DFUR to be a useful treatment for advanced colon cancer. 相似文献
90.
Horiuchi H Ishikawa H Hiraki M Uchida S Yasunaga M Ohdo M Tamae T Fukuda S Hara M Okuda K Kinoshita H Aoyagi S Shirouzu K Koganemaru M 《Gan to kagaku ryoho. Cancer & chemotherapy》2002,29(12):2065-2069
PURPOSE: Most patients with pancreatic cancer are unresectable because of local invasion and liver metastasis at the time of diagnosis. To date, no treatment has had a significant impact on this disease. To deliver a high concentration of drug to the cancer, intra-arterial chemotherapy with GEM was performed in two patients with unresectable advanced cancer. PATIENTS AND METHODS: One patient, a 70-year-old man with liver metastasis, was treated with arterial infusion of GEM 1,000 mg/body. Another patient, a 55-year-old woman with local invasion and distant metastatic lymphadenopathy, was given intra-arterial infusion of GEM 400 mg and intra-venous infusion of GEM 1,000 mg/body. The patients were given GEM weekly for 3 weeks followed by a week of rest. RESULTS: In the first patient, the pain went away and CEA was decreased for 6 months. After that, the patient died due to intra-abdominal dissemination within 4 months. In the other patient, the pain went away. Tumor markers, such as CEA and CA19-9, were normalized and primary pancreatic cancer was reduced locally. The patient currently has a metastatic liver tumor, but she has had a significant improvement in performance status. CONCLUSION: Intra-arterial chemotherapy with GEM may be tolerated in patients with unresectable pancreatic cancer. 相似文献